These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19561425)

  • 1. Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors.
    Andiman WA; Chernoff MC; Mitchell C; Purswani M; Oleske J; Williams PL; Spiegel H; Gona P; Seage GR;
    Pediatr Infect Dis J; 2009 Jul; 28(7):619-25. PubMed ID: 19561425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children.
    Gaughan DM; Mofenson LM; Hughes MD; Seage GR; Ciupak GL; Oleske JM;
    Pediatrics; 2002 May; 109(5):E74-4. PubMed ID: 11986480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS.
    Pryce C; Pierre RB; Steel-Duncan J; Evans-Gilbert T; Palmer P; Moore J; Rodriguez B; Christie CD
    West Indian Med J; 2008 Jun; 57(3):238-45. PubMed ID: 19583122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
    Mocroft A; Lundgren JD; Ross M; Fux CA; Reiss P; Moranne O; Morlat P; Monforte Ad; Kirk O; Ryom L;
    Lancet HIV; 2016 Jan; 3(1):e23-32. PubMed ID: 26762990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal manifestations in HIV-infected Jamaican children.
    Steel-Duncan J; Miller M; Pierre RB; Dunkley-Thompson J; Palmer P; Evans-Gilbert T; Rodriquez B; Christie CD;
    West Indian Med J; 2008 Jun; 57(3):246-52. PubMed ID: 19583123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
    Crain MJ; Williams PL; Griner R; Tassiopoulos K; Read JS; Mofenson LM; Rich KC;
    Pediatr Infect Dis J; 2011 Dec; 30(12):1069-74. PubMed ID: 22051859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent sterile leukocyturia is associated with impaired renal function in human immunodeficiency virus type 1-infected children treated with indinavir.
    van Rossum AM; Dieleman JP; Fraaij PL; Cransberg K; Hartwig NG; Burger DM; Gyssens IC; de Groot R
    Pediatrics; 2002 Aug; 110(2 Pt 1):e19. PubMed ID: 12165618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women.
    Gardner LI; Holmberg SD; Williamson JM; Szczech LA; Carpenter CC; Rompalo AM; Schuman P; Klein RS;
    J Acquir Immune Defic Syndr; 2003 Feb; 32(2):203-9. PubMed ID: 12571531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.
    Neilan AM; Karalius B; Patel K; Van Dyke RB; Abzug MJ; Agwu AL; Williams PL; Purswani M; Kacanek D; Oleske JM; Burchett SK; Wiznia A; Chernoff M; Seage GR; Ciaranello AL;
    JAMA Pediatr; 2017 May; 171(5):450-460. PubMed ID: 28346597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
    PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric hospitalizations among children and youths with human immunodeficiency virus infection.
    Gaughan DM; Hughes MD; Oleske JM; Malee K; Gore CA; Nachman S;
    Pediatrics; 2004 Jun; 113(6):e544-51. PubMed ID: 15173535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
    Brady MT; Oleske JM; Williams PL; Elgie C; Mofenson LM; Dankner WM; Van Dyke RB;
    J Acquir Immune Defic Syndr; 2010 Jan; 53(1):86-94. PubMed ID: 20035164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia.
    Joshi K; Boettiger D; Kerr S; Nishijima T; Van Nguyen K; Ly PS; Lee MP; Kumarasamy N; Wong W; Kantipong P; Cuong DD; Kamarulzaman A; Choi JY; Zhang F; Chaiwarith R; Ng OT; Kiertiburanakul S; Sim BLH; Merati TP; Yunihastuti E; Ditangco R; Ross J; Pujari S
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1209-1216. PubMed ID: 30246898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV.
    Crain MJ; Chernoff MC; Oleske JM; Brogly SB; Malee KM; Borum PR; Meyer WA; Mitchell WG; Moye JH; Ford-Chatterton HM; Van Dyke RB; Seage Iii GR
    J Infect Dis; 2010 Jul; 202(2):291-301. PubMed ID: 20533872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Ylitalo N; Brogly S; Hughes MD; Nachman S; Dankner W; Van Dyke R; Seage GR;
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):778-87. PubMed ID: 16894075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of proteinuria among HIV-infected children attending a tertiary hospital in Lagos, Nigeria.
    Esezobor CI; Iroha E; Onifade E; Akinsulie AO; Temiye EO; Ezeaka C
    J Trop Pediatr; 2010 Jun; 56(3):187-90. PubMed ID: 19793893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children.
    Kalyesubula I; Musoke-Mudido P; Marum L; Bagenda D; Aceng E; Ndugwa C; Olness K
    Pediatr Infect Dis J; 1997 Sep; 16(9):876-81. PubMed ID: 9306483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease associated with perinatal HIV infection in children and adolescents.
    Purswani MU; Chernoff MC; Mitchell CD; Seage GR; Zilleruelo G; Abitbol C; Andiman WA; Kaiser KA; Spiegel H; Oleske JM;
    Pediatr Nephrol; 2012 Jun; 27(6):981-9. PubMed ID: 22366874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute.
    Starc TJ; Lipshultz SE; Kaplan S; Easley KA; Bricker JT; Colan SD; Lai WW; Gersony WM; Sopko G; Moodie DS; Schluchter MD
    Pediatrics; 1999 Aug; 104(2):e14. PubMed ID: 10429132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.